Drugmakers Fight to Preserve Industry-Funded CME

Drug Industry Daily
A A
Pharmaceutical companies want to maintain the current exemption on reporting financial support for continuing medical education (CME) programs under the Physician Payment Sunshine Act, a position that is under threat from a new proposed rule.

To View This Article:

Login

Subscribe To Drug Industry Daily